You are here

bladder cancer

ESMO: Merck's Keytruda-chemo combo shows survival 'trend,' but can't top chemo in bladder cancer

Fierce Pharma

Sat, 09/19/20 - 09:11 pm

metastatic bladder cancer

Seattle Genetics stays step ahead of rivals with bladder cancer data

BioPharma Dive

Sat, 09/19/20 - 09:04 pm

Seattle Genetics

clinical trials

AZ aims to cut cancer clinic visits with new Imfinzi regimen

Pharmaforum

Tue, 08/18/20 - 10:58 am

Merck & Co’s Keytruda fails in first line bladder cancer

Pharmaforum

Wed, 06/10/20 - 10:51 am

ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer

Fierce Pharma

Thu, 05/28/20 - 11:08 pm

gestational trophoblastic tumors

clinical trials

Seattle Genetics' bladder cancer med Padcev blows early expectations out of the water

Fierce Pharma

Tue, 05/5/20 - 12:47 pm

Seattle Genetics

Seattle could waltz in where Astra failed

EP Vantage

Fri, 03/6/20 - 10:34 am

Seattle Genetics

clinical trials

Pharma New Astellas, Seattle Genetics Padcev combo data spark $5.8B sales hopes

Fierce Pharma

Fri, 02/14/20 - 05:07 pm

Seattle Genetics

advanced bladder cancer

Seattle Genetics, Astellas Says 73% Of Bladder Cancer Patients On Padcev Had Confirmed Tumor Response

Reuters

Tue, 02/11/20 - 10:46 am

Seattle Genetics

Roche's Tecentriq fails trial in form of urothelial cancer

Reuters

Fri, 01/24/20 - 10:08 am

clinical trials

urothelial cancer

Merck's Blockbuster Drug Wins Key New FDA Approval

Motley Fool

Thu, 01/9/20 - 10:57 am

Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores

Endpoints

Mon, 01/6/20 - 10:16 am

Merck’s Keytruda nabs FDA panel's favor to line up for new bladder cancer OK

Fierce Pharma

Wed, 12/18/19 - 10:50 am

FerGene’s Bladder Cancer Phase III Trial Hits Its Mark

BioSpace

Fri, 12/6/19 - 10:09 am

Ferring Pharmaceuticals

Blackstone Life Sciences

clinical trials

Merck’s Keytruda gets FDA priority review for high-risk NMIBC

Pharmaceutical Business Review

Mon, 12/2/19 - 10:46 am

priority review

ESMO: Astellas, Seattle Genetics' Keytruda combo shrinks 71% of bladder cancers

Fierce Biotech

Sat, 09/28/19 - 04:36 pm

Seattle Genetics

enfortumab vedotin

urothelial cancer

Oncologists listen when the FDA speaks, even after a drug hits the market

Endpoints

Thu, 09/26/19 - 10:47 am

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Pharmaceutical Business Review

Sat, 08/10/19 - 01:54 pm

clinical trials

Roche says test showed Tecentriq helped vs bladder cancer

Reuters

Mon, 08/5/19 - 11:03 am

Did cancer clinical trials stay on track at ASCO 2019?

Pharmaforum

Fri, 07/19/19 - 01:00 pm

clinical trials

prostate cancer

pancreatic cancer

Pages